Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wolfgang

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|July 1, 1992
Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitorsJ H Condra, E A Emini, L Gotlib, et al.
The American Journal of Physiology|June 11, 1999
NO modulates myocardial O2 consumption in the nonhuman primate: an additional mechanism of action of amlodipineP R Forfia, X Zhang, D R Knight, et al.
The Journal of Biological Chemistry|September 5, 1992
Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitorsV V Sardana, E A Emini, L Gotlib, et al.
Practical Radiation Oncology|November 22, 2014
Deep inspiration breath-hold technique in left-sided breast cancer radiation therapy: Evaluating cardiac contact distance as a predictor of cardiac exposure for patient selectionNathalie Rochet, Julie I Drake, Kyla Harrington, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1994
Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitorsV W Byrnes, E A Emini, W A Schleif, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1993
Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitorsV W Byrnes, V V Sardana, W A Schleif, et al.
International Journal of Radiation Oncology, Biology, Physics|February 5, 2023
Predictive Model of Liver Toxicity to Aid the Personalized Selection of Proton Versus Photon Therapy in Hepatocellular CarcinomaIbrahim Chamseddine, Yejin Kim, Brian De, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2020
Dosimetric Analysis and Normal-Tissue Complication Probability Modeling of Child-Pugh Score and Albumin-Bilirubin Grade Increase After Hepatic IrradiationJennifer Pursley, Issam El Naqa, Nina N Sanford, et al.
Practical Radiation Oncology|September 7, 2014
A prospective feasibility study of respiratory-gated proton beam therapy for liver tumorsTheodore S Hong, Thomas F DeLaney, Harvey J Mamon, et al.
International Journal of Radiation Oncology, Biology, Physics|June 4, 2018
Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver CancerClemens Grassberger, Theodore S Hong, Tai Hato, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|July 1, 1992
Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitorsJ H Condra, E A Emini, L Gotlib, et al.
The American Journal of Physiology|June 11, 1999
NO modulates myocardial O2 consumption in the nonhuman primate: an additional mechanism of action of amlodipineP R Forfia, X Zhang, D R Knight, et al.
The Journal of Biological Chemistry|September 5, 1992
Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitorsV V Sardana, E A Emini, L Gotlib, et al.
Practical Radiation Oncology|November 22, 2014
Deep inspiration breath-hold technique in left-sided breast cancer radiation therapy: Evaluating cardiac contact distance as a predictor of cardiac exposure for patient selectionNathalie Rochet, Julie I Drake, Kyla Harrington, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1994
Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitorsV W Byrnes, E A Emini, W A Schleif, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1993
Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitorsV W Byrnes, V V Sardana, W A Schleif, et al.
International Journal of Radiation Oncology, Biology, Physics|February 5, 2023
Predictive Model of Liver Toxicity to Aid the Personalized Selection of Proton Versus Photon Therapy in Hepatocellular CarcinomaIbrahim Chamseddine, Yejin Kim, Brian De, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2020
Dosimetric Analysis and Normal-Tissue Complication Probability Modeling of Child-Pugh Score and Albumin-Bilirubin Grade Increase After Hepatic IrradiationJennifer Pursley, Issam El Naqa, Nina N Sanford, et al.
Practical Radiation Oncology|September 7, 2014
A prospective feasibility study of respiratory-gated proton beam therapy for liver tumorsTheodore S Hong, Thomas F DeLaney, Harvey J Mamon, et al.
International Journal of Radiation Oncology, Biology, Physics|June 4, 2018
Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver CancerClemens Grassberger, Theodore S Hong, Tai Hato, et al.
Pageof 4